Clinical validation of Grewia tenax fruits extract chewble tablets in treatment of iron deficiency anemia [retrospectively registered]

Randomized control trial to validate Grewi tenax fruits extract chewable tablets in the treatment of iron deficiency anemia in adults. A pilot study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201111000337258

Enrollment

Registered

2011-11-10

Start date

2011-06-06

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Haematological Disorders Nutritional, Metabolic, Endocrine iron deficiency and iron deficiency anemia

Interventions

Ferrous gluconate tablets

Grewia tenax fruits extract

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Inclusion criteria: Volunteer adults 18 years and older diagnosed and confirmed to have iron deficiency whose hemoglobin measurements are 78% g/dl or less who may or may not have iron deficiency symptoms to be recruited after signing an informed consent.

Exclusion criteria

Exclusion criteria: Exclusion Criteria: Other types of anemias other than iron deficiency GIT disorders that may interfere with oral absorption All hemoglobinopathies and blood disorders Other comorbidities that may confound the results outcome as seen by the supervising physicians

Design outcomes

Primary

Measure	Time frame
Hemoglobin level, reticulocyte count and full iron profile	—

Secondary

Measure	Time frame
Reported adverse effects with each treatment arm and clinical improvement of anemia	—

Countries

Sudan

Contacts

Public ContactRanda AlMahdi

primary investigator

randa_almahdi@yahoo.com00249912147698

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026